Principal Investigator

Carl D. Novina MD, PhD is an Associate Professor of Medicine at the Dana-Farber Cancer Institute & Harvard Medical School and an Associate Member of the Broad Institute of Harvard and MIT. His lab has made several discoveries about the fundamental biology of noncoding RNAs and their dysregulation in cancers. His lab has also developed platform technologies to discover and drug non-coding RNAs and build tools for epigenetic engineering and Boolean logic gated cell therapies. He has founded three companies to accelerate the translation of these tools to the clinic. Dr. Novina is the recipient of numerous awards and honors including the W.M. Keck Distinguished Young Scholars Award, Department of Defense Idea Award, The NCI Director’s Provocative Questions Award, the National Science Foundation Collaborative Research Project Award and the NIH Director’s Pioneer Award.